Replikins' BioRadar(TM) Announced by UK Trade and Investment

Tuesday, March 30, 2010 Press Release
Email Print This Page Comment
Font : A-A+



LONDON, March 29 UK Trade and Investment (http://www.newsroom.uktradeinvest.gov.uk/news.ashx) has announced the formation of BioRadar UK Limited. BioRadar is building on the recent success of Replikins' genomic analysis of influenza viruses in predicting the outbreaks of both H5N1 (bird flu) 6 months in advance, and H1N1 (swine flu) one year in advance.

A global surveillance network for Early Detection->Rapid Response(TM), based on quantitative determination of Replikins in genomes of infectious organisms, is being formed with participating laboratories in Europe.

Up to the present, infectious diseases of animals and man repeatedly emerge with little or no warning, and devastate their host populations before effective preventative or restrictive efforts can be instituted.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

Contact: Samuel Bogoch, MD, PhD sbogoch@replikins.com 516-729-6461

SOURCE Replikins


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook